chr7-96191188-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_014251.3(SLC25A13):​c.675G>A​(p.Ser225Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00182 in 1,613,758 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S225S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0094 ( 25 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 16 hom. )

Consequence

SLC25A13
NM_014251.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.88

Publications

2 publications found
Variant links:
Genes affected
SLC25A13 (HGNC:10983): (solute carrier family 25 member 13) This gene is a member of the mitochondrial carrier family. The encoded protein contains four EF-hand Ca(2+) binding motifs in the N-terminal domain, and localizes to mitochondria. The protein catalyzes the exchange of aspartate for glutamate and a proton across the inner mitochondrial membrane, and is stimulated by calcium on the external side of the inner mitochondrial membrane. Mutations in this gene result in citrullinemia, type II. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
SLC25A13 Gene-Disease associations (from GenCC):
  • citrin deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • citrullinemia, type II, adult-onset
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • neonatal intrahepatic cholestasis due to citrin deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet
  • citrullinemia type II
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 7-96191188-C-T is Benign according to our data. Variant chr7-96191188-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 361025.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.88 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00943 (1433/152020) while in subpopulation AFR AF = 0.0332 (1377/41466). AF 95% confidence interval is 0.0317. There are 25 homozygotes in GnomAd4. There are 650 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014251.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC25A13
NM_014251.3
MANE Select
c.675G>Ap.Ser225Ser
synonymous
Exon 7 of 18NP_055066.1Q9UJS0-1
SLC25A13
NM_001160210.2
c.675G>Ap.Ser225Ser
synonymous
Exon 7 of 18NP_001153682.1Q9UJS0-2
SLC25A13
NR_027662.2
n.701G>A
non_coding_transcript_exon
Exon 6 of 17

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC25A13
ENST00000265631.10
TSL:1 MANE Select
c.675G>Ap.Ser225Ser
synonymous
Exon 7 of 18ENSP00000265631.6Q9UJS0-1
SLC25A13
ENST00000416240.6
TSL:1
c.675G>Ap.Ser225Ser
synonymous
Exon 7 of 18ENSP00000400101.2Q9UJS0-2
SLC25A13
ENST00000856215.1
c.675G>Ap.Ser225Ser
synonymous
Exon 7 of 19ENSP00000526274.1

Frequencies

GnomAD3 genomes
AF:
0.00943
AC:
1432
AN:
151902
Hom.:
25
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0333
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00265
AC:
665
AN:
251144
AF XY:
0.00194
show subpopulations
Gnomad AFR exome
AF:
0.0354
Gnomad AMR exome
AF:
0.00185
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00102
AC:
1497
AN:
1461738
Hom.:
16
Cov.:
31
AF XY:
0.000865
AC XY:
629
AN XY:
727176
show subpopulations
African (AFR)
AF:
0.0344
AC:
1150
AN:
33472
American (AMR)
AF:
0.00195
AC:
87
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53396
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000764
AC:
85
AN:
1111934
Other (OTH)
AF:
0.00263
AC:
159
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
79
159
238
318
397
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00943
AC:
1433
AN:
152020
Hom.:
25
Cov.:
32
AF XY:
0.00875
AC XY:
650
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.0332
AC:
1377
AN:
41466
American (AMR)
AF:
0.00177
AC:
27
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10536
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
67996
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
70
139
209
278
348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00421
Hom.:
3
Bravo
AF:
0.0105
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Citrin deficiency (1)
-
-
1
Citrullinemia (1)
-
-
1
Citrullinemia type I (1)
-
-
1
Citrullinemia type II (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
2.2
DANN
Benign
0.44
PhyloP100
-2.9
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78247004; hg19: chr7-95820500; API